Autumn Ehnow

Autumn Ehnow has twenty years of experience leading pharmaceutical development teams and managing business partnerships. She has led several partnerships with governmental agencies and private pharmaceutical companies for the development of new medicines aimed at creating social change.

As part of the team that started Medicines360, Ms. Ehnow was integral in defining and leading strategy and program implementation. This work continues today with a focus on addressing market access barriers and implementing a public affairs strategy to secure patients’ access to treatment.

Her career has consisted of ten years in for-profit pharmaceutical companies and ten years in non-profit pharmaceutical companies. At the Institute for OneWorld Health, Ms. Ehnow was integral in forming and managing the Bill and Melinda Gates Foundation grant and the four-company partnership that brought semi-synthetic Artemisinin to market.

As a patient advocate in her personal time, Ms. Ehnow has a deep commitment to helping others. She has spent over twenty years volunteering for the Arthritis Foundation and served on its National Board of Directors.

Ms. Ehnow received her BS in Molecular and Cellular Biology from the University of Arizona.